Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Keep drug firms out of primary care

While I can see the point in allowing some alternative providers into the primary care sector (May 3), the idea of drugs companies running chronic disease management is rather like putting Dracula in charge of the blood transfusion service.

This opportunity would enable drugs companies to profit twice from disease, first by charging the PCT for their services, and then for providing the drugs recommended by these services. This is a route to very biased prescribing, and increased drug company profits. There is no guarantee the patient's interests will feature in any of the transactions.

The conflict of interest in such an arrangement is huge, and the benefit appears only to be for the drugs company. There already is a service available to provide chronic disease management and, given the right investment, GP practices will do it very well.

Why are ministers looking to fragment primary care rather than improve what is already there?

Dr Peter Davies

Mixenden, Halifax

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say